| Green synthesis of silver nanoparticles using green tea leaves: Experimental study on the morphological, rheological and antibacterial behaviour M Nakhjavani, V Nikkhah, MM Sarafraz, S Shoja, M Sarafraz Heat and Mass Transfer 53, 3201-3209, 2017 | 180 | 2017 |
| Thermal performance of a heat sink microchannel working with biologically produced silver-water nanofluid: Experimental assessment MM Sarafraz, V Nikkhah, M Nakhjavani, A Arya Experimental Thermal and Fluid Science 91, 509-519, 2018 | 135 | 2018 |
| Fouling formation and thermal performance of aqueous carbon nanotube nanofluid in a heat sink with rectangular parallel microchannel MM Sarafraz, V Nikkhah, M Nakhjavani, A Arya Applied Thermal Engineering 123, 29-39, 2017 | 112 | 2017 |
| Remarks in successful cellular investigations for fighting breast cancer using novel synthetic compounds FH Shirazi, A Zarghi, F Kobarfard, R Zendehdel, M Nakhjavani, S Arfaiee, ... Breast Cancer-Focusing Tumor Microenvironment, Stem cells and Metastasis …, 2011 | 71 | 2011 |
| Anti-angiogenic properties of ginsenoside Rg3 M Nakhjavani, E Smith, AR Townsend, TJ Price, JE Hardingham Molecules 25 (21), 4905, 2020 | 66 | 2020 |
| Anticancer activity a of caspian cobra (Naja naja oxiana) snake venom in human cancer cell lines via induction of apoptosis K Ebrahim, H Vatanpour, A Zare, FH Shirazi, M Nakhjavani Iranian journal of pharmaceutical research: IJPR 15 (Suppl), 101, 2016 | 66 | 2016 |
| Druggable molecular targets for the treatment of triple negative breast cancer M Nakhjavani, JE Hardingham, HM Palethorpe, TJ Price, AR Townsend Journal of breast cancer 22 (3), 341, 2019 | 57 | 2019 |
| Ginsenoside Rg3: Potential molecular targets and therapeutic indication in metastatic breast cancer M Nakhjavani, JE Hardingham, HM Palethorpe, Y Tomita, E Smith, ... Medicines 6 (1), 17, 2019 | 54 | 2019 |
| Intracellular GSH alterations and its relationship to level of resistance following exposure to cisplatin in cancer cells B Jamali, M Nakhjavani, L Hosseinzadeh, S Amidi, N Nikounezhad, ... Iranian journal of pharmaceutical research: IJPR 14 (2), 513, 2015 | 48 | 2015 |
| Stereoselective anti-cancer activities of ginsenoside Rg3 on triple negative breast cancer cell models M Nakhjavani, HM Palethorpe, Y Tomita, E Smith, TJ Price, AJ Yool, ... Pharmaceuticals 12 (3), 117, 2019 | 40 | 2019 |
| Bacopasides I and II act in synergy to inhibit the growth, migration and invasion of breast cancer cell lines HM Palethorpe, E Smith, Y Tomita, M Nakhjavani, AJ Yool, TJ Price, ... Molecules 24 (19), 3539, 2019 | 39 | 2019 |
| Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer M Nakhjavani, S Shigdar Pharmacological research 175, 106019, 2022 | 33 | 2022 |
| Generation of cisplatin-resistant ovarian cancer cell lines N Nikounezhad, M Nakhjavani, FH Shirazi IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES 12 (1), 11-20, 2016 | 31 | 2016 |
| FTIR-microspectroscopy detection of metronidazole teratogenic effects on mice fetus A Ashtarinezhad, FH Shirazi, H Vatanpour, B Mohamazadehasl, ... Iranian journal of pharmaceutical research: IJPR 13 (Suppl), 101, 2014 | 30 | 2014 |
| Evaluation of silibinin effects on the viability of HepG2 (human hepatocellular liver carcinoma) and HUVEC (human umbilical vein endothelial) cell lines NV Zahir, M Nakhjavani, P Hajian, FH Shirazi, H Mirzaei Iranian journal of pharmaceutical research: IJPR 17 (1), 261, 2018 | 29 | 2018 |
| Cytotoxicity of selected novel chalcone derivatives on human breast, lung and hepatic carcinoma cell lines M Nakhjavani, A Zarghi, FH Shirazi Iranian journal of pharmaceutical research: IJPR 13 (3), 953, 2014 | 27 | 2014 |
| Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin. N Nikounezhad, M Nakhjavani, FH Shirazi Journal of experimental therapeutics & oncology 12 (1), 2017 | 24 | 2017 |
| Bumetanide-derived aquaporin 1 inhibitors, AqB013 and AqB050 inhibit tube formation of endothelial cells through induction of apoptosis and impaired migration in vitro Y Tomita, HM Palethorpe, E Smith, M Nakhjavani, AR Townsend, TJ Price, ... International Journal of Molecular Sciences 20 (8), 1818, 2019 | 23 | 2019 |
| Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options M Nakhjavani, RM Samarasinghe, S Shigdar Drug Discovery Today 27 (5), 1298-1314, 2022 | 22 | 2022 |
| Cytotoxicity of Diimine Palladium (II) Complexes of Alkyldithiocarbamate Derivatives on Human Lung, Ovary and Liver Cells N Aryanpour, H Mansouri-Torshizi, M Nakhjavan, F H. Shirazi Iranian Journal of Pharmaceutical Research 11 (2), 689-695, 2012 | 22 | 2012 |
Timothy PriceThe Queen Elizabeth Hospital and School of Medicine University of AdelaideVerified email at adelaide.edu.au